Nozaki Yuka, Mizunoe Yuhei, Kobayashi Masaki, Higami Yoshikazu
Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo 125-8585, Japan.
Department of Nutrition and Food Science, Graduate School of Humanities and Sciences, Ochanomizu University, Tokyo 112-8610, Japan.
Int J Mol Sci. 2025 Sep 19;26(18):9172. doi: 10.3390/ijms26189172.
WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) is a member of the homologous to E6AP C-terminus-type E3 ubiquitin protein ligase family. Although WWP1 plays a role in several human diseases, including infectious diseases, neurological disorders, and cancers, there is emerging evidence that WWP1 is also associated with metabolic disorders. In this review, we discuss the regulation and molecular function of WWP1 and its contribution to obesity-related metabolic disorders, particularly in white adipose tissue and the liver. We highlight the need for further research to deepen our understanding of how WWP1 may be implicated in metabolic dysfunction and facilitate the development of novel therapeutic strategies that target WWP1.
含WW结构域的E3泛素蛋白连接酶1(WWP1)是E6AP C末端型E3泛素蛋白连接酶家族的同源成员。尽管WWP1在包括传染病、神经疾病和癌症在内的多种人类疾病中发挥作用,但越来越多的证据表明,WWP1也与代谢紊乱有关。在这篇综述中,我们讨论了WWP1的调控和分子功能及其对肥胖相关代谢紊乱的影响,特别是在白色脂肪组织和肝脏中的影响。我们强调需要进一步研究,以加深我们对WWP1如何参与代谢功能障碍的理解,并促进针对WWP1的新型治疗策略的开发。